205 related articles for article (PubMed ID: 19908293)
1. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.
Allen CE; Flores R; Rauch R; Dauser R; Murray JC; Puccetti D; Hsu DA; Sondel P; Hetherington M; Goldman S; McClain KL
Pediatr Blood Cancer; 2010 Mar; 54(3):416-23. PubMed ID: 19908293
[TBL] [Abstract][Full Text] [Related]
2. VCR/AraC chemotherapy and ND-CNS-LCH.
Imashuku S; Shioda Y; Tsunematsu Y; Imamura T; Morimoto A;
Pediatr Blood Cancer; 2010 Jul; 55(1):215-6. PubMed ID: 20310001
[No Abstract] [Full Text] [Related]
3. CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.
McClain KL; Picarsic J; Chakraborty R; Zinn D; Lin H; Abhyankar H; Scull B; Shih A; Lim KPH; Eckstein O; Lubega J; Peters TL; Olea W; Burke T; Ahmed N; Hicks MJ; Tran B; Jones J; Dauser R; Jeng M; Baiocchi R; Schiff D; Goldman S; Heym KM; Wilson H; Carcamo B; Kumar A; Rodriguez-Galindo C; Whipple NS; Campbell P; Murdoch G; Kofler J; Heales S; Malone M; Woltjer R; Quinn JF; Orchard P; Kruer MC; Jaffe R; Manz MG; Lira SA; Parsons DW; Merad M; Man TK; Allen CE
Cancer; 2018 Jun; 124(12):2607-2620. PubMed ID: 29624648
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease.
Imashuku S; Fujita N; Shioda Y; Noma H; Seto S; Minato T; Sakashita K; Ito N; Kobayashi R; Morimoto A;
Int J Hematol; 2015 Feb; 101(2):191-7. PubMed ID: 25491495
[TBL] [Abstract][Full Text] [Related]
5. Treatment of neurodegenerative CNS disease in Langerhans cell histiocytosis with a combination of intravenous immunoglobulin and chemotherapy.
Imashuku S; Okazaki N'; Nakayama M; Fujita N; Fukuyama T; Koike K; Minato T; Kobayashi R; Morimoto A;
Pediatr Blood Cancer; 2008 Feb; 50(2):308-11. PubMed ID: 17458874
[TBL] [Abstract][Full Text] [Related]
6. Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution.
Egeler RM; de Kraker J; Voûte PA
Med Pediatr Oncol; 1993; 21(4):265-70. PubMed ID: 8469221
[TBL] [Abstract][Full Text] [Related]
7. High dose immunoglobulin (IVIG) may reduce the incidence of Langerhans cell histiocytosis (LCH)-associated central nervous system involvement.
Imashuku S
CNS Neurol Disord Drug Targets; 2009 Nov; 8(5):380-6. PubMed ID: 19702569
[TBL] [Abstract][Full Text] [Related]
8. Failure to treat obstructive hydrocephalus with endoscopic third ventriculostomy in a patient with neurodegenerative Langerhans cell histiocytosis.
Kershenovich A; Price AV; Koral K; Goldman S; Swift DM
J Neurosurg Pediatr; 2008 Nov; 2(5):304-9. PubMed ID: 18976098
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the Prevention of Central Nervous System Complications in Patients with Langerhans Cell Histiocytosis: The Problem of Neurodegenerative Syndrome.
Imashuku S; Arceci RJ
Hematol Oncol Clin North Am; 2015 Oct; 29(5):875-93. PubMed ID: 26461148
[TBL] [Abstract][Full Text] [Related]
10. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
[TBL] [Abstract][Full Text] [Related]
11. Pattern and course of neurodegeneration in Langerhans cell histiocytosis.
Wnorowski M; Prosch H; Prayer D; Janssen G; Gadner H; Grois N
J Pediatr; 2008 Jul; 153(1):127-32. PubMed ID: 18571550
[TBL] [Abstract][Full Text] [Related]
12. Recognition and treatment of concurrent active and neurodegenerative langerhans cell histiocytosis: a case report.
Ehrhardt MJ; Karst J; Donohoue PA; Maheshwari M; McClain KL; Bingen K; Kelly ME
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e37-40. PubMed ID: 24322503
[TBL] [Abstract][Full Text] [Related]
13. Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone.
Wang W; Ge J; Ma H; Lian H; Cui L; Zhao Y; Li Z; Wang T; Zhang R
BMC Pediatr; 2024 Jan; 24(1):1. PubMed ID: 38172736
[TBL] [Abstract][Full Text] [Related]
14. MRI features of neurodegenerative Langerhans cell histiocytosis.
Martin-Duverneuil N; Idbaih A; Hoang-Xuan K; Donadieu J; Genereau T; Guillevin R; Chiras J;
Eur Radiol; 2006 Sep; 16(9):2074-82. PubMed ID: 16625352
[TBL] [Abstract][Full Text] [Related]
15. Long-term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow-up of the JLSG-96/02 studies.
Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
Br J Haematol; 2021 Feb; 192(3):615-620. PubMed ID: 33236384
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar ataxia in pediatric patients with Langerhans cell histiocytosis.
Imashuku S; Ishida S; Koike K; Ichikawa M; Minato T; Suzuki Y; Kobayashi R; Morimoto A;
J Pediatr Hematol Oncol; 2004 Nov; 26(11):735-9. PubMed ID: 15543008
[TBL] [Abstract][Full Text] [Related]
17. Second-line regimen for CNS-involved pediatric Langerhans cell histiocytosis.
Lian H; Cui L; Yang Y; Wei A; Cheng H; Li N; Zhang L; Ma H; Zhao X; Wang T; Li Z; Zhang R
Pituitary; 2022 Feb; 25(1):108-115. PubMed ID: 34302575
[TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.
Apollonsky N; Lipton JM
J Pediatr Hematol Oncol; 2009 Jan; 31(1):53-6. PubMed ID: 19125089
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study.
Ng Wing Tin S; Martin-Duverneuil N; Idbaih A; Garel C; Ribeiro M; Parker JL; Defachelles AS; Lambilliotte A; Barkaoui M; Munzer M; Gardembas M; Sibilia J; Lutz P; Fior R; Polak M; Robert A; Aumaitre O; Plantaz D; Armari-Alla C; Genereau T; Berard PM; Talom GN; Pennaforte JL; Le Pointe HD; Barthez MA; Couillault G; Haroche J; Mokhtari K; Donadieu J; Hoang-Xuan K;
Orphanet J Rare Dis; 2011 Dec; 6():83. PubMed ID: 22151964
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Langerhans cell histiocytosis with subcutaneous cytarabine.
Eckstein OS; Bernhardt MB; Hood CG; Karri V; Kralik SF; McClain KL
Pediatr Hematol Oncol; 2023; 40(5):497-505. PubMed ID: 36625721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
